ORBIMED CAPITAL LLC's Net Worth
$266 Million
Who is ORBIMED CAPITAL LLC?
ORBIMED CAPITAL LLC has an estimated net worth of $266 Million. This is based on reported shares across multiple companies, which include ChemoCentryx, Inc., Arcutis Biotherapeutics, Inc., Sierra Oncology, Inc., PMV Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Alector, Inc., Prelude Therapeutics Inc, Kinnate Biopharma Inc., Repare Therapeutics Inc., MEMORY PHARMACEUTICALS CORP, ORTHOVITA INC, ORPHAN MEDICAL INC, AEROGEN INC, DOV PHARMACEUTICAL INC, ARS Pharmaceuticals, Inc., Fusion Pharmaceuticals Inc., CRYOCOR INC, IMARA Inc., GIVEN IMAGING LTD, and LIFECELL CORP.
SEC CIK
ORBIMED CAPITAL LLC's CIK is 0001157524
Past Insider Trading and Trends
2020 was ORBIMED CAPITAL LLC's most active year for acquiring shares with 38 total transactions. ORBIMED CAPITAL LLC's most active month to acquire stocks was the month of January. 2020 was ORBIMED CAPITAL LLC's most active year for disposing of shares, totalling 32 transactions. ORBIMED CAPITAL LLC's most active month to dispose stocks was the month of November. 2020 saw ORBIMED CAPITAL LLC paying a total of $133,250,313.00 for 47,384,731 shares, this is the most they've acquired in one year. In 2022 ORBIMED CAPITAL LLC cashed out on 5,624,015 shares for a total of $143,777,775.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ChemoCentryx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.15M |
—
|
—
| 3.15M |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.735
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.97% | -341.97K |
$21.31 | -$7,287,402.01 | 3.95M |
Jun 24
| |||
Form 4
| -6.06% | -878.20K |
$20.69 | -$18,163,608.12 | 13.62M |
Apr 6 - Apr 8
| |||
Form 4
| +10.61% | 496K |
$25.00 | $12,400,000.00 | 5.17M |
Oct 2
| |||
Form 4
| +836.28% | 4.67M |
$17.00 | $9,501,096.00 | 5.23M |
Feb 3 - Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.96M |
$55.00 | -$108,062,350.00 |
0
|
Jul 1
| |||
Form 4
| +33.00% | 487.45K |
$13.20 | $6,434,340.00 | 1.96M |
Jan 26
| |||
Form 4
|
∞
| 1.48M |
—
|
—
| 1.48M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -474.50K |
$21.63 | -$10,264,415.00 |
0
|
Mar 29 - Mar 31
| |||
Form 4
|
∞
| 7.06M |
$18.00 | $8,550,000.00 | 7.06M |
Sep 25 - Sep 29
| |||
| No matching records found | |||||||||
Decibel Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +161.61% | 4.95M |
$18.00 | $29,999,988.00 | 8.01M |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||